Madlen Löbel
From MEpedia, a crowd-sourced encyclopedia of ME and CFS science and history
(Redirected from Madlen Loebel)
Madlen Löbel or Madlen Loebel, PhD, is a post-doctorate with the Institute of Medical Immunology, Charité University Medicine Berlin, Campus Virchow, Berlin, Germany. Her expertise is in Infectious Diseases and Clinical Immunology.
Doctorate thesis[edit | edit source]
- 2011 - Title of PhD project: Interaction of the matricellular protein CCN1 with immune cells.[1]
Awards[edit | edit source]
- 2016 Ramsay Award Program grant recipient, sponsored by the Solve ME/CFS Initiative for Autoimmune Signature in CFS/ME. This grant was shared with Carmen Scheibenbogen, Charité Universitätsmedizin Berlin.[2]
Notable studies[edit | edit source]
- 2014, Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome[3] (Full Text)
- 2015, Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome[4] (Full Text)
- 2015, Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome[5] (Full Text)
- 2016, Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome[6] (Full Text)
- 2017, Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray[7] (Full Text)
- 2018, Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME[8] (Full Text)
Talks and interviews[edit | edit source]
Online presence[edit | edit source]
Learn more[edit | edit source]
See also[edit | edit source]
References[edit | edit source]
- ↑ https://bsrt.cloud.opencampus.net/profile-doktorand/888
- ↑ http://solvecfs.org/2016-ramsay-award-program-results/
- ↑ Loebel, Madlen; Strohschein, Kristin; Giannini, Carolin; Koelsch, Uwe; Bauer, Sandra; Doebis, Cornelia; Thomas, Sybill; Unterwalder, Nadine; Baehr, Volker von (January 15, 2014). "Deficient EBV-Specific B- and T-Cell Response in Patients with Chronic Fatigue Syndrome". PLOS ONE. 9 (1): e85387. doi:10.1371/journal.pone.0085387. ISSN 1932-6203.
- ↑ Guenther, Sabrina; Loebel, Madlen; Mooslechner, Agnes A; Knops, Michael; Hanitsch, Leif G; Grabowski, Patricia; Wittke, Kirsten; Meisel, Christian; Unterwalder, Nadine; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Frequent IgG subclass and mannose binding lectin deficiency in patients with chronic fatigue syndrome", Human Immunology, 76 (10): 729-35, doi:10.1016/j.humimm.2015.09.028
- ↑ Loebel, Madlen; Mooslechner, Agnes Anna; Bauer, Sandra; Günther, Sabrina; Letsch, Anne; Hanitsch, Leif G; Grabowski, Patricia; Meisel, Christian; Volk, Hans-Dieter; Scheibenbogen, Carmen (2015), "Polymorphism in COMT is associated with IgG3 subclass level and susceptibility to infection in patients with chronic fatigue syndrome", Journal of Translational Medicine, 13, doi:10.1186/s12967-015-0628-4
- ↑ Loebel, M; Grabowski, P; Heidecke, H; Bauer, S; Hanitsch, LG; Wittke, K; Meisel, C; Reinke, P; Volk, H; Fluge, Ø; Mella, O; Scheibenbogen, C (2016), "Antibodies to β adrenergic and muscarinic cholinergic receptors in patients with Chronic Fatigue Syndrome", Brain, behavior, and immunity, 52: 32-39, doi:10.1016/j.bbi.2015.09.013
- ↑ Loebel, Madlen; Eckey, Maren; Sotzny, Franziska; Hahn, Elisabeth; Bauer, Sandra; Grabowski, Patricia; Zerweck, Johannes; Holenya, Pavlo; Hanitsch, Leif G.; Wittke, Kirsten; Borchmann, Peter; Rüffer, Jens-Ulrich; Hiepe, Falk; Ruprecht, Klemens; Behrends, Uta; Meindl, Carola; Volk, Hans-Dieter; Reimer, Ulf; Scheibenbogen, Carmen (2017), "Serological profiling of the EBV immune response in Chronic Fatigue Syndrome using a peptide microarray", PLOS ONE, 12 (6): e0179124, doi:10.1371/journal.pone.0179124
- ↑ Scheibenbogen, Carmen; Loebel, Madlen; Freitag, Helma; Krueger, Anne; Bauer, Sandra; Antelmann, Michaela; Doehner, Wolfram; Scherbakov, Nadja; Heidecke, Harald; Reinke, Petra; Volk, Hans-Dieter; Grabowski, Patricia (2018). "Immunoadsorption to remove ß2 adrenergic receptor antibodies in Chronic Fatigue Syndrome CFS/ME". PLoS ONE. 13 (3): e0193672. doi:10.1371/journal.pone.0193672.
